Protocol Citation: Nathan Wright 2025. Large scale MPro MERS-CoV protein expression setup and operation of Single Use Bubble Column Reactors : Litre-Scale Expression of Recombinant Proteins for Structural Biology and Drug Design (SBDD). protocols.io https://dx.doi.org/10.17504/protocols.io.e6nvwqw6dvmk/v1 License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Protocol status: WorkingWe use this protocol and it's working
Created: June 12, 2025
Last Modified: June 20, 2025
Protocol Integer ID: 220062
Keywords: Single-Use, Bubble Column Reactor, protein production, SBDD, MPro, MERS-CoV, E.coli, significant advancement in protein production methodology, protein production methodology, cov mpro protein with high yield, protein production methodology for structural biology, cov protein expression setup, recombinant protein production, cov mpro protein, use bubble column reactor, scale expression of recombinant protein, structural biology pipeline, bubble column reactor, overnight protein expression at ambient temperature, requiring multiple protein construct, overnight protein expression, multiple protein, cov main protease, multiple protein constructs for crystallographic study, recombinant protein, purification, using disposable bioreactor bag, protein, bottleneck of insufficient protein quantity, high protein quantity, practical solution for laboratory, drug discovery application, disposable bioreactor bag, magnetic bead purification, large scale mpro mer, based drug discovery, main protease, successful protein overexpres
Funders Acknowledgements:National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)
Grant ID: U19AI171399